Clinical Trial Update: Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient Tachypnoea [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating inhaled furosemide for transient tachypnea of the newborn has completed (status: COMPLETED).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transient Tachypnea of the Newborn

Drugs mentioned

• Furosemide inhalation (furosemide)

Snippet

Sponsor: University of Cologne | Conditions: Transient Tachypnoea of the Newborn | Phase 2 | Status: COMPLETED